Photo
Corps éditorial
Accumulating evidence on the long-term immunogenicity of fractional dosing for yellow fever vaccines.
Référence de l'article:
The Lancet. Infectious diseases 2024 Feb 06; . doi: 10.1016/S1473-3099(24)00008-2. Epub 2024 02 06
The life-long protective immunity of yellow fever vaccination: time to review?
Référence de l'article:
The Lancet. Global health 2024 Jan 22; . doi: 10.1016/S2214-109X(23)00594-6. Epub 2024 01 22
Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in children (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial.
Référence de l'article:
The Lancet. Infectious diseases 2023 Apr 28; . doi: 10.1016/S1473-3099(23)00131-7. Epub 2023 04 28
Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in HIV-infected people in Kenya (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial.
Référence de l'article:
The Lancet. Infectious diseases 2023 Apr 28; . doi: 10.1016/S1473-3099(23)00114-7. Epub 2023 04 28
Immunogenicity and safety of fractional doses of yellow fever vaccines: a randomised, double-blind, non-inferiority trial.
Référence de l'article:
Lancet (London, England) 2021 Jan 09; 397(10269); 119-127. doi: 10.1016/S0140-6736(20)32520-4. Epub 2021 01 10
Humoral and cellular immune response induced by rVSVΔG-ZEBOV-GP vaccine among frontline workers during the 2013-2016 West Africa Ebola outbreak in Guinea.
Référence de l'article:
Vaccine 2020 Jun 01; doi: 10.1016/j.vaccine.2020.04.066. Epub 2020 06 01
Evaluation of the stability of measles vaccine out of the cold chain under extended controlled temperature conditions.
Référence de l'article:
Vaccine 2020 Feb 08; doi: 10.1016/j.vaccine.2020.02.005. Epub 2020 02 08
Factors influencing participation in an Ebola vaccine trial among front-line workers in Guinea.
Référence de l'article:
Vaccine 2019 Oct 14; doi: 10.1016/j.vaccine.2019.09.094. Epub 2019 10 14
Safety of the rVSV ZEBOV vaccine against Ebola Zaire among frontline workers in Guinea.
Référence de l'article:
Vaccine 2018 Sep 25; doi: 10.1016/j.vaccine.2018.09.009. Epub 2018 09 25
Randomized, double-blinded, controlled non-inferiority trials evaluating the immunogenicity and safety of fractional doses of Yellow Fever vaccines in Kenya and Uganda
Référence de l'article:
Wellcome Open Research 2019 Nov 21; 4:182;10.12688/wellcomeopenres.15579.1
Characteristics of human encounters and social mixing patterns relevant to infectious diseases spread by close contact: a survey in Southwest Uganda.
Référence de l'article:
BMC infectious diseases 2018 04 11; 18(1); 172. doi: 10.1186/s12879-018-3073-1. Epub 2018 04 11
Vaccination in humanitarian crises: satisficing should no longer suffice.
Référence de l'article:
International health 2014 Sep ; 6(3); 160-1. doi: 10.1093/inthealth/ihu051. Epub 2014 08 04
Local discrepancies in measles vaccination opportunities: results of population-based surveys in Sub-Saharan Africa.
Référence de l'article:
BMC public health 2014 Feb 21; 14 193. doi: 10.1186/1471-2458-14-193. Epub 2014 02 21
A cluster randomized non-inferiority field trial on the immunogenicity and safety of tetanus toxoid vaccine kept in controlled temperature chain compared to cold chain.
Référence de l'article:
Vaccine 2014 Oct 29; 32(47); 6220-6. doi: 10.1016/j.vaccine.2014.09.027. Epub 2014 09 26